ArticlePloS one2026

Retraction: Synergistic Antitumor Effects of Novel HDAC Inhibitors and Paclitaxel In Vitro and In Vivo.

PLOS One EditorsPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.